published

Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery

MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination…

5 months ago

Para Snow Sports classification: Part 2 The process of classification

Jul 17, 2025 - Learn about all aspects of the classification process across Para Alpine, Para Cross-Country and Para Snowboard in…

5 months ago

ISC2 Research Reveals Cybersecurity Teams Are Taking a Cautious Approach to AI Adoption

New study reveals 30% of cybersecurity professionals are already using AI tools, delivering insights into the early impact on team…

5 months ago

CGTN: Bridging dialogue: China promotes integration, mutual learning among civilizations

With the Global Civilizations Dialogue Ministerial Meeting taking place in Beijing on July 10 and 11, CGTN published an article…

5 months ago

CGTN: Why does China honor the spirit of resisting aggression?

BEIJING, July 9, 2025 /PRNewswire/ -- CGTN has published an article on why China will commemorate the 80th anniversary of…

5 months ago

Clarivate Releases 2025 G20 Research and Innovation Scorecard Highlighting Global Collaboration and Impact

New Data Reveals Shifting Global Partnerships, Rising Open Access, and Focus on SDG-Aligned Research LONDON, July 9, 2025 /PRNewswire/ -- Clarivate…

5 months ago

Euro NCAP to Launch New Round of 2025 Safety Results

WhatLatest Euro NCAP safety results published online and via social media.WhenWednesday 9 July - 11:00 a.m. CEST.WhereGo to Euro NCAP's…

5 months ago

Para Snow Sports classification: Part 1 Research and collaboration to ensure fair competition

Jul 04, 2025 - Learn about all aspects of the classification process across Para Alpine, Para Cross-Country and Para Snowboard in…

5 months ago

NEXEN TIRE Releases 2024/25 Sustainability Report, Strengthens ESG Commitments Across Global Operations

First-time inclusion of consolidated global performance data from 10 international sitesExpanded focus on low-carbon technologies, biodiversity stewardship, and workplace safetyAdvances…

6 months ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction in the highest range of…

6 months ago